If you have a low-risk prostate cancer that is unlikely to progress, your doctor may suggest holding off on treatment and doingactive surveillance instead.The idea is that most prostate cancers grow ...
SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results